NO307656B1 - Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider - Google Patents

Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider

Info

Publication number
NO307656B1
NO307656B1 NO933397A NO933397A NO307656B1 NO 307656 B1 NO307656 B1 NO 307656B1 NO 933397 A NO933397 A NO 933397A NO 933397 A NO933397 A NO 933397A NO 307656 B1 NO307656 B1 NO 307656B1
Authority
NO
Norway
Prior art keywords
terminal
oligoribonucleotides
junctions
nucleotides
manufacture
Prior art date
Application number
NO933397A
Other languages
English (en)
Norwegian (no)
Other versions
NO933397D0 (no
NO933397L (no
Inventor
Heinz Hartmut Seliger
Flavio Ramalho Ortigao
Hannelore Roesch
Rudi Roesch
Bernd Krist
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6468696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307656(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO933397D0 publication Critical patent/NO933397D0/no
Publication of NO933397L publication Critical patent/NO933397L/no
Publication of NO307656B1 publication Critical patent/NO307656B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Shaping Of Tube Ends By Bending Or Straightening (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO933397A 1992-09-24 1993-09-23 Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider NO307656B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4231949 1992-09-24

Publications (3)

Publication Number Publication Date
NO933397D0 NO933397D0 (no) 1993-09-23
NO933397L NO933397L (no) 1994-03-25
NO307656B1 true NO307656B1 (no) 2000-05-08

Family

ID=6468696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933397A NO307656B1 (no) 1992-09-24 1993-09-23 Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider

Country Status (14)

Country Link
US (1) US6420546B1 (el)
EP (1) EP0593901B2 (el)
JP (1) JP3653102B2 (el)
AT (1) ATE151773T1 (el)
AU (1) AU665113B2 (el)
CA (1) CA2106819C (el)
DE (1) DE59306170D1 (el)
DK (1) DK0593901T3 (el)
ES (1) ES2103408T3 (el)
FI (1) FI115400B (el)
GR (1) GR3023858T3 (el)
HU (1) HU219638B (el)
NO (1) NO307656B1 (el)
NZ (1) NZ248739A (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646042A (en) * 1992-08-26 1997-07-08 Ribozyme Pharmaceuticals, Inc. C-myb targeted ribozymes
US5998203A (en) * 1996-04-16 1999-12-07 Ribozyme Pharmaceuticals, Inc. Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
PT808898E (pt) * 1996-05-24 2004-10-29 Aventis Pharma Gmbh Reagente e metodo para inibicao da expressao de n-ras
US7572582B2 (en) 1997-09-12 2009-08-11 Exiqon A/S Oligonucleotide analogues
CA2326823A1 (en) * 1998-04-20 1999-10-28 Ribozyme Pharmaceuticals, Inc. Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
EP2322648A1 (en) 2000-09-26 2011-05-18 Duke University RNA aptamers and methods for identifying the same
SG157961A1 (en) 2001-05-25 2010-01-29 Univ Duke Modulators of pharmacological agents
KR101147147B1 (ko) 2004-04-01 2012-05-25 머크 샤프 앤드 돔 코포레이션 Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
ES2494940T3 (es) 2004-04-22 2014-09-16 Regado Biosciences, Inc. Moduladores de factores de coagulación mejorados
US7923206B2 (en) 2004-11-22 2011-04-12 Dharmacon, Inc. Method of determining a cellular response to a biological agent
US7923207B2 (en) 2004-11-22 2011-04-12 Dharmacon, Inc. Apparatus and system having dry gene silencing pools
US7935811B2 (en) 2004-11-22 2011-05-03 Dharmacon, Inc. Apparatus and system having dry gene silencing compositions
EP1820804A1 (en) * 2006-02-20 2007-08-22 Humboldt-Universität zu Berlin Lipidated oligonucleotides
WO2008036841A2 (en) 2006-09-22 2008-03-27 Dharmacon, Inc. Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
US7845686B2 (en) * 2007-12-17 2010-12-07 S & B Technical Products, Inc. Restrained pipe joining system for plastic pipe
US8188060B2 (en) 2008-02-11 2012-05-29 Dharmacon, Inc. Duplex oligonucleotides with enhanced functionality in gene regulation
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
CN110023321A (zh) 2016-08-17 2019-07-16 索尔斯蒂斯生物有限公司 多核苷酸构建体
EP3645546A4 (en) 2017-06-30 2021-12-01 Solstice Biologics, Ltd. CHIRAL PHOSPHORAMIDITIS AUXILIARIES AND THEIR METHODS OF USE
US11104941B2 (en) * 2018-09-28 2021-08-31 Bioo Scientific Corporation 5′ adapter comprising an internal 5′-5′ linkage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916871A1 (de) 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
ES2099718T3 (es) * 1990-07-02 1997-06-01 Hoechst Ag Analogos de oligonucleotidos con uniones internucleotidicas de 3'-3' o 5'-5' terminales.
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
KR930016437A (ko) * 1992-01-22 1993-08-26 귀틀라인, 슈미트 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도

Also Published As

Publication number Publication date
NO933397D0 (no) 1993-09-23
CA2106819A1 (en) 1994-03-25
ES2103408T3 (es) 1997-09-16
EP0593901B1 (de) 1997-04-16
AU665113B2 (en) 1995-12-14
FI934154A (fi) 1994-03-25
FI934154A0 (fi) 1993-09-22
NO933397L (no) 1994-03-25
JP3653102B2 (ja) 2005-05-25
NZ248739A (en) 1995-08-28
AU4755193A (en) 1994-03-31
HU219638B (hu) 2001-06-28
HU9302697D0 (en) 1993-12-28
US6420546B1 (en) 2002-07-16
EP0593901A2 (de) 1994-04-27
EP0593901A3 (en) 1994-09-28
DE59306170D1 (de) 1997-05-22
GR3023858T3 (en) 1997-09-30
HUT66458A (en) 1994-11-28
ATE151773T1 (de) 1997-05-15
DK0593901T3 (da) 1997-10-27
CA2106819C (en) 2007-04-17
EP0593901B2 (de) 2008-04-09
JPH06189753A (ja) 1994-07-12
FI115400B (fi) 2005-04-29

Similar Documents

Publication Publication Date Title
NO307656B1 (no) Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider
ATE151076T1 (de) Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen
ATE419275T1 (de) Antikörper gegen vla-4
DE3889346D1 (de) Mittel zur Arzneistoffabgabe und Verfahren zu deren Herstellung.
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
DE69233117D1 (de) In sich geschlossende "sens-" und "antisense"-oligonukleotide und deren verwendungen
DK0725648T3 (da) Leverspecifikke farmaceutiske aktivstoffer
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
DE69203104T2 (de) Herstellung von zellularen Elastomeren und chemische Zusammensetzungen zu deren Herstellung.
DE68925004D1 (de) Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen.
WO2000069901A3 (en) Proteins with insulin-like activity useful in the treatment of diabetes
EP0749312A4 (en) DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE
DE69400342D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluor-2-Chlorethan und Pentafluorethan
DE69524971T2 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
DE3683249D1 (de) 2-aminosulfonyl-6-nitrobenzoesaeureester oder amide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX22991A (es) Agente edulcorante derivado del acido l-aspartico o l-glutamico y el procedimiento para su preparacion.
ITMI921235A0 (it) Oligonucleotidi antisenso ad attivita' antitumorale, composizioni farmaceutiche li comprendono e loro impieghi
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
DE59300883D1 (de) Verfahren zur Herstellung von Dianthrachinon-N,N'-dihydroazin und dessen Chlorierungsprodukten.
DE69326050T2 (de) Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
RU93054766A (ru) Олигорибонуклеотиды и их рибозимные аналоги с концевыми 3'-3'-соответственно, 5'-5'-связями
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
DE69226336T2 (de) Formmasse, enthaltend feuerfeste Fasern, verwendbar in der Herstellung ablativer Teile, Verfahren zu ihrer Herstellung und ihre Anwendungen
DE59310291D1 (de) Fluorierte 1,3-Benzo- und 1,3-Pyrido-dioxole, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Pflanzenschutzmitteln